首页> 美国政府科技报告 >Teratologic Evaluation of alpha-Methyldopa (CAS No. 555-30-6) Administered to CD Rats on Gestational Days 6 through 20
【24h】

Teratologic Evaluation of alpha-Methyldopa (CAS No. 555-30-6) Administered to CD Rats on Gestational Days 6 through 20

机译:妊娠期第6至20天给予CD大鼠α-甲基多巴(Cas号555-30-6)的畸形评价

获取原文

摘要

Alpha-Methyldopa (MD), a widely used antihypertensive, was evaluated for toxic and teratogenic effects in timed-pregnant CD rats exposed to MD on gestational days (gd) 6 through 20 and sacrificed on gd 20. Prior to the initiation of the teratology study, a preliminary study was conducted in order to establish appropriate doses for use in the teratology study. In the preliminary dose range-finding study, MD, suspended in corn oil, was administered by gavage to timed-pregnant CD rats at doses of 0, 100, 250, 500, 750, and 1000 mg/kg/day (6 animals/group) on gd 6 through 20. Animals were sacrificed and evaluated on gd 20. The results of the preliminary dose range-finding study indicated that the 1000 mg/kg/day dose caused 33% mortality of confirmed-pregnant dams, and was therefore unsuitable for use in the teratology study. A probit plot analysis of the mortality data from the preliminary study suggested an LD10 of 581 mg/kg/day. Accordingly, doses of 0, 50, 100, 250, and 500 mg/kg/day MD were chosen for administration in the teratology study.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号